Putting an end to speculation, Philip Morris International (NYSE: PM) Tuesday confirmed it is in merger talks with rival tobacco company Altria Group (MO). Meanwhile, a statement issued by Altria said it is pursuing a merger deal with Philip Morris. The planned all-stock deal is currently in the discussion stage.
Earlier, there were unconfirmed reports that the companies are planning to become a single entity, which sent Philip Morris’ stock falling during Monday’s trading session. The stock closed the session down about 4%. On the other hand, Altria shares traded sharply higher early Tuesday, after closing the last session higher.
While the merger theory has been doing the rounds for a long time, Altria’s interest in smoke-free cigarette brand iQOS – developed recently by Philip Morris – gives it a new perspective.
Confirming its outperform rating on Philip Morris and reiterating the $102 price target, Wells Fargo in a research note released yesterday attributed the negative stock movement to the Altria deal.
These days, the general market sentiment has not been in favor of Philip Morris, mainly due to lack of transparency in its strategy to move away from conventional cigarettes to smokeless alternatives. Recent studies have found that most of the smoke-free tobacco products are not as safe as they are made out to be.
However, recent data show that Philip Morris’ shift to smokeless products has been well received so far. Last month, the company reported in-line revenues for the second quarter, with the only segment that recorded year-over-growth being Heated Tobacco.
Shares of Philip Morris traded down 6% during Tuesday’s early hours, after closing the previous session lower. Altria was up 8% soon after the session started.
Most Popular
United Parcel Service (UPS) seems on track to regain lost strength
Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic
IPO Alert: What to look for when Boundless Bio goes public
Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.
Nike (NKE) bets on innovation and partnerships to return to high growth
Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company
Comments
Comments are closed.